Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1067]
News [1573]
Articles [102]
Editorials [10]
Conferences [134]
elearning [2]
Discussion: Additional treatment options impact first-line treatment of mRCC
Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
Discussion: Additional treatment options impact first-line treatment of mRCC ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014
ecancermedicalscience editor's choice for September 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for September 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Sep 2014
Benefits of investing in skin cancer prevention
Craig Sinclair - Cancer Council Victoria, Victoria, Australia
Benefits of investing in skin cancer prevention ( Craig Sinclair - Cancer Council Victoria, Victoria, Australia )
11 Sep 2014
Skin cancer across the world and ways of preventing risk
Prof Adele Green - Deputy Director, Queensland Institute of Medical Research...
Skin cancer across the world and ways of preventing risk ( Prof Adele Green - Deputy Director, Queensland Institute of Medical Research, Brisbane, Australia )
11 Sep 2014
Risk of common skin cancer increased by as much as 90 per cent with sunbeds...
Patrick Tierney - University of Dundee, Dundee, UK
Risk of common skin cancer increased by as much as 90 per cent with sunbeds, study finds ( Patrick Tierney - University of Dundee, Dundee, UK )
11 Sep 2014
Moles on the skin increase skin cancer risk
Dr Eugene Ong - University of Oxford, Oxford, UK
Moles on the skin increase skin cancer risk ( Dr Eugene Ong - University of Oxford, Oxford, UK )
11 Sep 2014
Global prostate cancer disparities and the parts both genetic and behavioural...
Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville...
Global prostate cancer disparities and the parts both genetic and behavioural factors play ( Dr Folakemi Odedina - College of Pharmacy, University of Florida, Gainesville, USA )
28 Aug 2014
Benefits of metronomic chemotherapy and the aims of the Metronomic Global...
Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France
Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative ( Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France )
10 Jul 2014
Tackling inequality in access to cancer care and information
Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Tackling inequality in access to cancer care and information ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014
ecancermedicalscience Editor's Choice for May 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for May 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
20 May 2014
Rituximab versus idelalisib in refractory CLL
Prof John Gribben - Queen Mary University London, London, UK; Prof Peter...
Rituximab versus idelalisib in refractory CLL ( Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )
9 May 2014
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic...
Dr Valentin Goede - University of Cologne, Cologne, Germany
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients ( Dr Valentin Goede - University of Cologne, Cologne, Germany )
8 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation